Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic StrokePierre Amarenco, Charlotte Rosso, Éric Vicaut et al.|Stroke|2020Cited by 59
Intracranial Hemorrhage in the TST TrialPierre Amarenco, Sophie Crozier, Julien Labreuche et al.|Stroke|2021Cited by 25
Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical OutcomeMarie‐Christine Alessi, Norbert Nighoghossian, Christophe Gaudin et al.|Cerebrovascular Diseases|2016Cited by 17
More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a StrokePierre Amarenco, Charlotte Rosso, Philippa C. Lavallée et al.|Stroke|2023Cited by 10